Skip to main content
CTY logo

CTY · City Therapeutics, Inc. · Shareholders & Ownership

Track CTY — free
$20.43 -1.04 (-4.82%)
Market Cap
$1.08B
Shares
50.33M
Volume · Oct 20 130.94K Avg daily vol (2 sessions) 854.41K

Every disclosed holder of CTY in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns CTY

No chart: shares outstanding cannot be set against these holders.

Holder group Shares % Out
Institutional (13F) 0 —
Insiders (Forms 3, 4, 5) 31,000,621 —
13D/G-only blocks 0 —
Registered funds (N-PORT, not summed) 0 —

% Out is unavailable: no shares outstanding count is on record.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of CTY

# Holder Shares
1
ARCH Venture Partners XII, LLC
Insider CIK 1979548 · Oct 19, 2026
10% Owner, issuer-wide
13,692,507
2
NELSEN ROBERT
Insider CIK 1219042 · Oct 19, 2026
Director, 10% Owner, issuer-wide
13,692,507
3
MARAGANORE JOHN
Insider CIK 1180432 · Oct 19, 2026
Director, issuer-wide
1,789,199
4
ORTH ANDREW C.
Insider CIK 1860010 · Oct 15, 2026
Chief Commercial Officer, issuer-wide
1,063,154
5
Trousil Sebastian
Insider CIK 2158853 · Oct 15, 2026
Chief Operating Officer, issuer-wide
534,511
6
Mei Baisong
Insider CIK 1938499 · Oct 15, 2026
EVP, CHIEF MEDICAL OFFICER, issuer-wide
228,743

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.